Navigation Links
Reportlinker Adds Clinical Laboratory Testing Volume 1: Reagents and Instruments
Date:8/25/2010

NEW YORK, Aug. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Clinical Laboratory Testing Volume 1: Reagents and Instruments

http://www.reportlinker.com/p0284247/Clinical-Laboratory-Testing-Volume-1-Reagents-and-Instruments.html

Clinical laboratory analysis for in vitro diagnostic (IVD) testing is one of the most important sectors of medical care. By all accounts, it is very mature, large market employing over 100,000 laboratory workers, and spawning an industry for reagents and instruments comprised of thousands of companies worldwide. The term clinical laboratory analysis usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations. The purpose of this TriMark Publications report is to describe the specific segments of the global clinical laboratory instrumentation and reagent market. Within this area, the report covers those segments that are highly active in terms of innovation and growth. Specifically, this global clinical laboratory markets report examines the markets for small lab equipment all the way up to highly-automated, large lab platforms, as well as accessory equipment such as reagents, supplies and manufacturers' original equipment manufacturer (OEM) additional equipment. The emphasis in this analysis is on those companies and products that are actively developing and marketing laboratory analyzer products for the clinical setting, including hospitals, independent
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reportlinker Adds Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016
2. Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
3. Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets
4. Reportlinker Adds Production and Market of Xylose in China
5. Reportlinker Adds Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED
6. Reportlinker Adds European Markets for Small Joint Reconstructive Devices 2010 (15 Countries)
7. Reportlinker Adds Japanese Market for Small Joint Reconstructive Devices 2010
8. Reportlinker Adds Effective Social Media Marketing Strategies for Pharmaceutical Market
9. Reportlinker Adds Wireless Medical Technologies 2007-2010
10. Reportlinker Adds European Market for Ventilation and Airway Management Devices
11. Reportlinker Adds Western European Disinfectant Gels and Scrubs Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 Amgen (NASDAQ: ... today declared a $0.79 per share dividend for the ... on Sept. 8, 2015, to all stockholders of record ... 2015.  About Amgen Amgen is committed ... from serious illnesses by discovering, developing, manufacturing and delivering ...
(Date:7/28/2015)... IRVINE, Calif., July 28, 2015  Edwards Lifesciences Corporation (NYSE: ... of heart valves and hemodynamic monitoring, today reported net ... million, or $1.02 per diluted share.  Adjusted net income ... per diluted share, compared to $0.88 per diluted share ... period, GAAP net income was $5.09 per diluted share, ...
(Date:7/28/2015)... LA JOLLA, Calif. , July 28, 2015 /PRNewswire/ ... a biopharmaceutical company leading the discovery and development of ... report financial results and highlights for the quarter ended ... the U.S. financial markets close. Regulus ... August 4, 2015, at 5:00 pm Eastern Daylight Time ...
Breaking Medicine Technology:Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Edwards Lifesciences Reports Second Quarter Results 2Edwards Lifesciences Reports Second Quarter Results 3Edwards Lifesciences Reports Second Quarter Results 4Edwards Lifesciences Reports Second Quarter Results 5Edwards Lifesciences Reports Second Quarter Results 6Edwards Lifesciences Reports Second Quarter Results 7Edwards Lifesciences Reports Second Quarter Results 8Edwards Lifesciences Reports Second Quarter Results 9Edwards Lifesciences Reports Second Quarter Results 10Edwards Lifesciences Reports Second Quarter Results 11Edwards Lifesciences Reports Second Quarter Results 12Edwards Lifesciences Reports Second Quarter Results 13Edwards Lifesciences Reports Second Quarter Results 14Edwards Lifesciences Reports Second Quarter Results 15Edwards Lifesciences Reports Second Quarter Results 16Edwards Lifesciences Reports Second Quarter Results 17Edwards Lifesciences Reports Second Quarter Results 18Edwards Lifesciences Reports Second Quarter Results 19Edwards Lifesciences Reports Second Quarter Results 20Edwards Lifesciences Reports Second Quarter Results 21Edwards Lifesciences Reports Second Quarter Results 22Edwards Lifesciences Reports Second Quarter Results 23Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3
... - Inovio Biomedical,Corporation (AMEX:INO), focused on the ... diseases and a novel alternative to,surgery to ... partner, Vical Incorporated, presented positive interim,safety and ... ongoing Phase I,clinical trial using Inovio's electroporation ...
... Clinical results from a,Phase II study presented ... Society (AHS) annual meeting showed that MK-0974, ... significantly improved migraine pain relief,two hours after ... was,sustained through 24 hours. MK-0974 was generally ...
Cached Medicine Technology:Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 2Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 3Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 4Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 5Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5
(Date:7/28/2015)... ... ... The insurance telematics or usage-based insurance (UBI) industry has long called for the ... data and better understand customer behavior behind the wheel. , Up until recently, ... changing and automakers realize that with the Internet of Things, new modes of mobility ...
(Date:7/28/2015)... ... July 28, 2015 , ... Santa Rosa’s The Press Democrat announced its annual report ... Dr. Francisco Canales and Dr. Heather Furnas took the top spot as the Best ... and Dr. Canales are proud to be bestowed such a prestigious title. , ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... ... and The Miriam Hospital examines outcomes for inmates who continued methadone maintenance treatment ... latter group was more likely to relapse to opiate use (1) and more ...
(Date:7/28/2015)... ... July 28, 2015 , ... Morristown Medical Center, part ... and one of the first five hospitals in the nation, to implant the newly ... on July 23, and all are in good condition. , The CoreValve® Evolut® R ...
(Date:7/28/2015)... San Francisco, California (PRWEB) , ... July 28, 2015 , ... ... released the results from a recent survey (1) examining consumers’ perspectives on ... during June 17-24, 2015, covered topics such as innovations in digital health, level of ...
Breaking Medicine News(10 mins):Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5
... has a greater impact on health than outdoor air ... their time indoors. Exposure to chemical and biological contaminants ... to the risk of developing respiratory and neurologic symptoms, ... the University of Ottawa; the Environmental Health Sciences Bureau ...
... it leads to damaged heart arteries later in life , , ... borderline high blood pressure called prehypertension are more likely later ... a new study finds. , "They,re too young to have ... J. Pletcher said of the 3,560 participants whose ages were ...
... Allows for a Single-Source Provider Solution for Ancillary Group ... ... Markets,division of Lincoln National Corporation (NYSE: LNC ) today announced it,will ... current,and future policyholders with effective dates of October 1, 2008. The,Lincoln DentalConnect(SM) ...
... report lower quality of life, poorer outlook , , MONDAY, July ... a person,s outlook on life, a new government study finds. ... lower on four scales measuring their quality of life, according ... Circulation , from researchers at the U.S. Centers for Disease ...
... The size of the financial burden on families with disabled ... to a new study conducted by the schools of social ... and Washington University in St. Louis, Mo. , According to ... burdens meaning in contrast, more vulnerable families in poorer ...
... Here are,highlights from the July issue of Mayo ... often as you wish. Mayo Clinic Women,s,HealthSource attribution ... the following subscription information as your editorial policies,permit: ... information, 800-876-8633, extension 9PK1., Vitamin D -- ...
Cached Medicine News:Health News:For Young Adults, Borderline High Blood Pressure a Threat 2Health News:Lincoln Financial Group Announces New Dental Panel of Providers 2Health News:Lincoln Financial Group Announces New Dental Panel of Providers 3Health News:Coronary Heart Disease Not a Cheery Condition 2Health News:Coronary Heart Disease Not a Cheery Condition 3Health News:UNC study: Out-of-pocket health care costs for disabled children vary widely by state 2Health News:July 2008 Mayo Clinic Women's HealthSource Highlights Vitamin D, Savvy Use of Sunscreen and Gastrointestinal Upset and Celiac Disease 2Health News:July 2008 Mayo Clinic Women's HealthSource Highlights Vitamin D, Savvy Use of Sunscreen and Gastrointestinal Upset and Celiac Disease 3Health News:July 2008 Mayo Clinic Women's HealthSource Highlights Vitamin D, Savvy Use of Sunscreen and Gastrointestinal Upset and Celiac Disease 4
Used in conjunction with the E5381 700 Circling Band (240 style). Indications: When high buckle is required. Overall length: 11.6 mm....
Concave inner surface. Used in conjunction with the E5381 700 Circling Band (240 style). Indications: When high buckle is required. Outside diameter 33.6 mm....
Asymmetrical concave inner surface to conform to globe. Used in conjunction with the E5381 700 Circling Band (240 style). Indications: Wide scleral bed. Outside diameter 31.7 mm....
Concave inner surface to conform to globe. Used in conjunction with the E5381 700 Circling Band (240 style). Indications: wide scleral bed. Outside diameter 31.7 mm....
Medicine Products: